首页> 外国专利> Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154

Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154

机译:聚乙二醇化的CD154肽和抑制CD154与CD154相互作用的方法

摘要

The present invention provides methods and materials for treating and preventing autoimmune diseases. In particular, the present invention relates to the discovery that small peptides are capable of interacting with CD40, thereby interfering with the ability of CD40 to interact with CD 154, which is important in inflammation. The present invention also relate to the use of such peptides in reducing the inflammatory response, and in particular, the autoimmune inflammatory response. The present invention also relates to the use of such short peptides to prevent or reverse autoimmune disease, and particular, diabetes, in individuals suffering from such disease. It also relates to methods and materials for detecting T-cells that express CD40 (Th40 cells). Also provided are kits for reducing inflammation, treating autoimmune diseases, or detecting Th40 cells.
机译:本发明提供了用于治疗和预防自身免疫疾病的方法和材料。特别地,本发明涉及发现小肽能够与CD40相互作用,从而干扰CD40与CD 154相互作用的能力,这在炎症中很重要。本发明还涉及此类肽在降低炎症反应,特别是自身免疫炎症反应中的用途。本发明还涉及这种短肽在预防或逆转自身免疫性疾病,特别是糖尿病,在患有这种疾病的个体中的用途。它还涉及用于检测表达CD40的T细胞(Th40细胞)的方法和材料。还提供了用于减少炎症,治疗自身免疫性疾病或检测Th40细胞的试剂盒。

著录项

  • 公开/公告号US9562088B2

    专利类型

  • 公开/公告日2017-02-07

    原文格式PDF

  • 申请/专利权人 DAVID WAGNER;

    申请/专利号US201113880387

  • 发明设计人 DAVID WAGNER;

    申请日2011-10-19

  • 分类号A61K38/00;C07K7/00;C07K14/705;A61K38/08;A61K38/10;A61K38/17;

  • 国家 US

  • 入库时间 2022-08-21 13:41:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号